Ethyl 2-ethyl-6-fluoro-5-[(2-methylpropan-2-yl)oxycarbonylamino]pyrazolo[1,5-a]pyridine-3-carboxylate
C17H22FN3O4 — CID 146267919
Data last refreshed: (MolForge compound catalog, from PubChem)
About Ethyl 2-ethyl-6-fluoro-5-[(2-methylpropan-2-yl)oxycarbonylamino]pyrazolo[1,5-a]pyridine-3-carboxylate
Ethyl 2-ethyl-6-fluoro-5-[(2-methylpropan-2-yl)oxycarbonylamino]pyrazolo[1,5-a]pyridine-3-carboxylate (PubChem CID 146267919) has the molecular formula C17H22FN3O4 and a molecular weight of 351.38 g/mol. Its IUPAC name is ethyl 2-ethyl-6-fluoro-5-[(2-methylpropan-2-yl)oxycarbonylamino]pyrazolo[1,5-a]pyridine-3-carboxylate.
Molecular Properties
| Compound Name | Ethyl 2-ethyl-6-fluoro-5-[(2-methylpropan-2-yl)oxycarbonylamino]pyrazolo[1,5-a]pyridine-3-carboxylate |
|---|---|
| PubChem CID | 146267919 |
| Molecular Formula | C17H22FN3O4 |
| Molecular Weight | 351.38 g/mol |
| Exact Mass | 351.16 |
| IUPAC Name | ethyl 2-ethyl-6-fluoro-5-[(2-methylpropan-2-yl)oxycarbonylamino]pyrazolo[1,5-a]pyridine-3-carboxylate |
| SMILES | CCOC(=O)c1c(CC)nn2cc(F)c(NC(=O)OC(C)(C)C)cc12 |
| InChI | InChI=1S/C17H22FN3O4/c1-6-11-14(15(22)24-7-2)13-8-12(10(18)9-21(13)20-11)19-16(23)25-17(3,4)5/h8-9H,6-7H2,1-5H3,(H,19,23) |
| InChIKey | UHLVHQMGNIWEII-UHFFFAOYSA-N |
| XLogP | 3.56 |
| TPSA | 81.93 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 25 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 351.38 |
| LogP ≤ 5 | 3.56 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 146267919 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.